What is the share price of Pharmaids Pharmaceuticals Ltd (PHARMAID) today?
The share price of PHARMAID as on 27th February 2026 is ₹31.89. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Pharmaids Pharmaceuticals Ltd (PHARMAID) share?
The past returns of Pharmaids Pharmaceuticals Ltd (PHARMAID) share are- Past 1 week: -12.63%
- Past 1 month: -24.89%
- Past 3 months: -30.67%
- Past 6 months: -48.03%
- Past 1 year: -55.09%
- Past 3 years: 17.53%
- Past 5 years: 129.82%
What are the peers or stocks similar to Pharmaids Pharmaceuticals Ltd (PHARMAID)?
The peers or stocks similar to Pharmaids Pharmaceuticals Ltd (PHARMAID) include:What is the market cap of Pharmaids Pharmaceuticals Ltd (PHARMAID) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pharmaids Pharmaceuticals Ltd (PHARMAID) is ₹110.88 Cr as of 27th February 2026.What is the 52 week high and low of Pharmaids Pharmaceuticals Ltd (PHARMAID) share?
The 52-week high of Pharmaids Pharmaceuticals Ltd (PHARMAID) is ₹75.98 and the 52-week low is ₹30.What is the PE and PB ratio of Pharmaids Pharmaceuticals Ltd (PHARMAID) stock?
The P/E (price-to-earnings) ratio of Pharmaids Pharmaceuticals Ltd (PHARMAID) is -10.31. The P/B (price-to-book) ratio is 2.01.Which sector does Pharmaids Pharmaceuticals Ltd (PHARMAID) belong to?
Pharmaids Pharmaceuticals Ltd (PHARMAID) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Pharmaids Pharmaceuticals Ltd (PHARMAID) shares?
You can directly buy Pharmaids Pharmaceuticals Ltd (PHARMAID) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Pharmaids Pharmaceuticals Ltd
PHARMAID Share Price
BSE₹31.892.18% (+0.68)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PHARMAID Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PHARMAID Performance & Key Metrics
PHARMAID Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -7.99 | 2.01 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.86 | 5.82 | 0.58% |
PHARMAID Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
PHARMAID Company Profile
Pharmaids Pharmaceuticals is engaged in the manufacturing of ayurvedic medicines and trading of allopathic medicines.
SUNPHARMA
PE Ratio
38.13
38.13
1Y Return
5.43%
5.43%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
76.73
76.73
1Y Return
45.07%
45.07%
Buy Reco %
81.48
81.48
CIPLA
PE Ratio
20.66
20.66
1Y Return
6.45%
6.45%
Buy Reco %
54.84
54.84
DRREDDY
PE Ratio
18.94
18.94
1Y Return
14.28%
14.28%
Buy Reco %
48.39
48.39
LUPIN
PE Ratio
32.06
32.06
1Y Return
21.73%
21.73%
Buy Reco %
72.22
72.22
PHARMAID Forecast
PHARMAID Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
PHARMAID
PHARMAID
Income
Balance Sheet
Cash Flow
Quarterly Normal View
PHARMAID Income Statement
PHARMAID Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | -0.26 | 0.78 | 5.93 | 4.74 | 5.32 | 4.72 | 4.90 | 6.70 | 11.63 | 5.51 | ||||||||||
Operating & Other expenses | 1.02 | 2.46 | 11.39 | 8.21 | 7.65 | 7.61 | 8.68 | 12.04 | 13.93 | 8.33 | ||||||||||
EBITDA | -1.28 | -1.68 | -5.46 | -3.47 | -2.33 | -2.89 | -3.78 | -5.34 | -2.30 | -2.82 | ||||||||||
| Depreciation/Amortization | 0.01 | 0.04 | 0.63 | 0.57 | 0.61 | 0.64 | 0.62 | 0.61 | 0.47 | 0.48 | ||||||||||
| PBIT | -1.29 | -1.72 | -6.09 | -4.04 | -2.94 | -3.53 | -4.40 | -5.95 | -2.77 | -3.30 | ||||||||||
| Interest & Other Items | 0.00 | 0.02 | 0.77 | 0.26 | 0.33 | 0.48 | 1.01 | 1.20 | 0.93 | 0.72 | ||||||||||
| PBT | -1.29 | -1.74 | -6.86 | -4.30 | -3.27 | -4.01 | -5.41 | -7.15 | -3.70 | -4.02 | ||||||||||
| Taxes & Other Items | -0.78 | -0.58 | -1.34 | -1.62 | -1.34 | -2.08 | -1.46 | -2.22 | -1.18 | -1.55 | ||||||||||
| Net Income | -0.51 | -1.16 | -5.52 | -2.68 | -1.93 | -1.93 | -3.95 | -4.93 | -2.52 | -2.47 | ||||||||||
| EPS | -0.24 | -0.54 | -2.82 | -0.76 | -0.73 | -0.55 | -1.11 | -1.39 | -0.70 | -0.70 |
PHARMAID Company Updates
PHARMAID Stock Peers
PHARMAID Past Performance & Peer Comparison
PHARMAID Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Pharmaids Pharmaceuticals Ltd | -10.31 | 2.01 | — |
| Sun Pharmaceutical Industries Ltd | 38.13 | 5.75 | 0.92% |
| Torrent Pharmaceuticals Ltd | 76.73 | 19.32 | 0.74% |
| Cipla Ltd | 20.66 | 3.48 | 1.19% |
PHARMAID Stock Price Comparison
Compare PHARMAID with any stock or ETFCompare PHARMAID with any stock or ETF
PHARMAID
PHARMAID Holdings
PHARMAID Shareholdings
PHARMAID Promoter Holdings Trend
PHARMAID Promoter Holdings Trend
PHARMAID Institutional Holdings Trend
PHARMAID Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PHARMAID Shareholding Pattern
PHARMAID Shareholding Pattern
PHARMAID Shareholding History
PHARMAID Shareholding History
Foreign Institutions
smallcases containing PHARMAID stock
smallcases containing PHARMAID stock
Looks like this stock is not in any smallcase yet.
PHARMAID Events
PHARMAID Events
PHARMAID Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PHARMAID has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PHARMAID Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PHARMAID has not given any dividends in last 5 years
PHARMAID Dividends
PHARMAID Dividends
Hmm, looks like data is unavailable here. Please come back after some timePHARMAID Stock News & Opinions
PHARMAID Stock News & Opinions
Articles & Videos
Earnings
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the December 2025 quarter
Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.48 crore in the quarter ended December 2025 as against net loss of Rs 1.93 crore during the previous quarter ended December 2024. Sales rose 15.29% to Rs 5.43 crore in the quarter ended December 2025 as against Rs 4.71 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales5.434.71 15 OPM %-46.22-61.36 - PBDT-3.15-3.36 6 PBT-3.62-4.00 10 NP-2.48-1.93 -28 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Pharmaids Pharmaceuticals schedules board meeting
Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the September 2025 quarter
Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.48 crore in the quarter ended September 2025 as against net loss of Rs 1.93 crore during the previous quarter ended September 2024. Sales rose 64.31% to Rs 8.61 crore in the quarter ended September 2025 as against Rs 5.24 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.615.24 64 OPM %-61.79-45.99 - PBDT-6.18-2.73 -126 PBT-6.65-3.34 -99 NP-2.48-1.93 -28 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Pharmaids Pharmaceuticals schedules board meeting
Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Pharmaids Pharmaceuticals schedules AGM
Pharmaids Pharmaceuticals announced that the 36th Annual General Meeting(AGM) of the company will be held on 23 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 4.95 crore in the June 2025 quarter
Net Loss of Pharmaids Pharmaceuticals reported to Rs 4.95 crore in the quarter ended June 2025 as against net loss of Rs 2.68 crore during the previous quarter ended June 2024. Sales rose 40.80% to Rs 6.66 crore in the quarter ended June 2025 as against Rs 4.73 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales6.664.73 41 OPM %-81.23-71.88 - PBDT-6.56-3.66 -79 PBT-7.17-4.22 -70 NP-4.95-2.68 -85 Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Pharmaids Pharmaceuticals reports standalone net loss of Rs 4.36 crore in the June 2025 quarter
Net Loss of Pharmaids Pharmaceuticals reported to Rs 4.36 crore in the quarter ended June 2025 as against net loss of Rs 1.62 crore during the previous quarter ended June 2024. Sales rose 558.82% to Rs 1.12 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1.120.17 559 OPM %-435.71-1005.88 - PBDT-5.64-1.72 -228 PBT-5.69-1.77 -221 NP-4.36-1.62 -169 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Pharmaids Pharmaceuticals to discuss results
Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 3.94 crore in the March 2025 quarter
Net Loss of Pharmaids Pharmaceuticals reported to Rs 3.94 crore in the quarter ended March 2025 as against net loss of Rs 5.52 crore during the previous quarter ended March 2024. Sales declined 17.90% to Rs 4.77 crore in the quarter ended March 2025 as against Rs 5.81 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 10.78 crore in the year ended March 2025 as against net loss of Rs 7.97 crore during the previous year ended March 2024. Sales rose 28.72% to Rs 19.45 crore in the year ended March 2025 as against Rs 15.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales4.775.81 -18 19.4515.11 29 OPM %-81.76-96.04 --65.55-87.43 - PBDT-4.84-6.23 22 -14.74-13.90 -6 PBT-5.46-6.86 20 -17.18-15.62 -10 NP-3.94-5.52 29 -10.78-7.97 -35 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Pharmaids Pharmaceuticals to discuss results
Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 27.85%
Pledged promoter holdings is insignificant